Lassila & Tikanoja plcStock Exhange Release6 May, 2025 at 3.20 pm Lassila & Tikanoja Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Teemu Kangas-Kärki Position: Member of the Board/Deputy member Issuer: Lassila & Tikanoja Oyj LEI: 743700Z9Z54VGHZA0028 Notification type: INITIAL NOTIFICATION Reference number: 106972/5/5 ____________________________________________ Transaction date: 2025-05-05 Outside a trading venue Instrument t ...

Core Insights - Windtree Therapeutics is advancing istaroxime, a potential treatment for cardiogenic shock, which may receive New Chemical Entity designation from the FDA, providing 7.5 years of U.S. exclusivity if approved [1][3] - Istaroxime has existing patents protecting its method of use until 2039 and a pending patent extending protection until 2043 [2] - The company is focused on the development of istaroxime, with an interim analysis of its Phase 2 study planned for Q3 2025 [3] Company Overview - Windtree Therapeutics is a biotechnology company aiming to generate revenue through innovative therapies for critical conditions, with istaroxime being a key candidate in its portfolio [5] - Istaroxime is a first-in-class dual-mechanism therapy designed to enhance both systolic and diastolic cardiac function, showing significant improvements in cardiac function and blood pressure in Phase 2 studies [4]

Lassila & Tikanoja plcStock Exhange Release6 May, 2025 at 3.15 pm Lassila & Tikanoja Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Tuija Kalpala Position: Member of the Board/Deputy member Issuer: Lassila & Tikanoja Oyj LEI: 743700Z9Z54VGHZA0028 Notification type: INITIAL NOTIFICATION Reference number: 106981/4/4 ____________________________________________ Transaction date: 2025-05-05 Outside a trading venue Instrument type: ...

Lassila & Tikanoja plcStock Exhange Release6 May, 2025 at 3.10 pm Lassila & Tikanoja Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Sakari Lassila Position: Member of the Board/Deputy member Issuer: Lassila & Tikanoja Oyj LEI: 743700Z9Z54VGHZA0028 Notification type: INITIAL NOTIFICATION Reference number: 106991/4/4 ____________________________________________ Transaction date: 2025-05-05 Outside a trading venue Instrument type: ...

Data from OVATION 2 trial will also be reviewed in an oral presentation at ASCO Annual Meeting on June 3, 2025 LAWRENCEVILLE, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today announced that data from the company’s Phase 1/2 OVATION 2 trial evaluating intraperitoneal IMNN-001 in combination with neoadjuvant and adjuvant chemotherapy in newly diagnosed patients with advanced epithelial ovarian canc ...

NEEDHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, announced today that management will present and participate in one-on-one meetings with investors at upcoming investor conferences. Bank of America Securities 2025 Health Care Conference (Las Vegas, NV)Presenter: Francesca Barone, MD, PhD, Candel’s Chief Scient ...

WEST PALM BEACH, FLORIDA, May 06, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., has reached key patient care milestones. Since operations commenced at its Oneida, Tennessee location in August 2023, the facility has seen over 400 patients and has served patients for over 5,000 care days. Robert Merritt, Chief of Executive Officer of Myrtle stated, “We are excited about reach ...

Lassila & Tikanoja plcStock Exhange Release6 May, 2025 at 3.05 pm Lassila & Tikanoja Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Jukka Leinonen Position: Member of the Board/Deputy member Issuer: Lassila & Tikanoja Oyj LEI: 743700Z9Z54VGHZA0028 Notification type: INITIAL NOTIFICATION Reference number: 106994/4/4 ____________________________________________ Transaction date: 2025-05-05 Outside a trading venue Instrument type: ...

WILMINGTON, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FSE: E30), a leading technology provider of Artificial Intelligence (AI) based next generation detection solutions to protect secure locations against prohibited weapons and other threats, is pleased to announce that the HEXWAVE™ recently completed operational test and evaluation at a major Category X airport in the US. Liberty’s HEXWAVE product, a next generation, walkth ...

Order reflects growing demand for ParaZero’s advanced drone safety solutions across the European commercial and enterprise sectors TEL AVIV, Israel, May 06, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the "company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aircrafts and defense Counter UAS systems, today announced that it has received a new order for dozens of units of its innovative SafeAir™ M4 system. The order was placed by a prominent ...